[{"NetIncomeLoss_1_Q3_USD":-27616000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q3_USD":8.26,"OperatingLeasesRentExpenseNet_1_Q3_USD":500000.0,"OperatingLeasesRentExpenseNet_3_Q3_USD":1800000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":26498000.0,"GainLossOnSaleOfPropertyPlantEquipment_3_Q3_USD":-89000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q3_USD":205722000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":7460000.0,"DepreciationAndAmortization_3_Q3_USD":1076000.0,"DepreciationAndAmortization_1_Q3_USD":300000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q3_USD":5.05,"MarketableSecuritiesCurrent_0_Q3_USD":286888000.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"HeldToMaturitySecurities_0_Q3_USD":304481000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":22841000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-301967000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":3177278.0,"ProceedsFromDivestitureOfBusinesses_3_Q3_USD":2400000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent_0_Q3_USD":2398000.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":293707000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.001,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_3_Q3_USD":6.03,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q3_shares":7963338.0,"Assets_0_Q3_USD":447396000.0,"CommonStockSharesIssued_0_Q3_shares":41162392.0,"OtherReceivables_0_Q3_USD":1059000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":3113000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":2961000.0,"DisposalGroupIncludingDiscontinuedOperationDeferredRevenue_0_Q3_USD":1239000.0,"RestructuringCharges_3_Q3_USD":63000.0,"AssetsCurrent_0_Q3_USD":415661000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":3182000.0,"Liabilities_0_Q3_USD":31794000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":444383000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":79865000.0,"OtherAssetsNoncurrent_0_Q3_USD":12470000.0,"LettersOfCreditOutstandingAmount_0_Q3_USD":500000.0,"AssetsFairValueDisclosure_0_Q3_USD":77895000.0,"DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets_0_Q3_USD":125000.0,"PrepaidExpenseCurrent_0_Q3_USD":6571000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":41088924.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":16616143.0,"HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_0_Q3_USD":8000.0,"ProceedsFromDivestitureOfBusinessesNetOfCashDivested_3_Q3_USD":17500000.0,"EarningsPerShareBasic_1_Q3_USD":-0.67,"EarningsPerShareBasic_3_Q3_USD":-2.74,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":10282000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q3_USD":8.26,"ResearchAndDevelopmentExpense_1_Q3_USD":24780000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":68501000.0,"DisposalGroupDeferredGainOnDisposal_0_Q3_USD":2242000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_3_Q3_pure":0.748,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":197000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1_Q3_pure":0.761,"IncomeTaxExpenseBenefit_1_Q3_USD":-3806000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1_Q3_pure":0.0036,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_3_Q3_pure":0.0109,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":355000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":-27616000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_3_Q3_USD":-45562000.0,"FairValueAdjustmentOfWarrants_3_Q3_USD":2597000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_3_Q3_USD":38647000.0,"RestrictedCash_0_Q3_USD":2470000.0,"AssetsOfDisposalGroupIncludingDiscontinuedOperation_0_Q3_USD":3640000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":293605000.0,"EmployeeBenefitsAndShareBasedCompensation_3_Q3_USD":4595000.0,"ContractWithCustomerAssetNet_0_Q3_USD":0.0,"DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_0_Q3_USD":1117000.0,"CommonStockValue_0_Q3_USD":41000.0,"InvestmentIncomeNetAmortizationOfDiscountAndPremium_3_Q3_USD":-192000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":-26529000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":5432000.0,"CommonStockSharesAuthorized_0_Q3_shares":150000000.0,"OperatingIncomeLoss_3_Q3_USD":-91405000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":3045000.0,"MarketableSecuritiesNoncurrent_0_Q3_USD":17593000.0,"OtherNonoperatingGainsLosses_1_Q3_USD":-52000.0,"OtherNonoperatingGainsLosses_3_Q3_USD":-2668000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":41088261.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":16616143.0,"ProceedsFromWarrantExercises_3_Q3_USD":12000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-83099000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":2129000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-31422000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-68355000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":11752000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q3_shares":4947106.0,"DeferredFederalIncomeTaxExpenseBenefit_3_Q3_USD":30300000.0,"EarningsPerShareDiluted_1_Q3_USD":-0.67,"LiabilitiesCurrent_0_Q3_USD":30666000.0,"EarningsPerShareDiluted_3_Q3_USD":-2.74,"AccountsPayableCurrent_0_Q3_USD":3717000.0,"NonoperatingIncomeExpense_1_Q3_USD":818000.0,"NetIncomeLoss_3_Q3_USD":-41826000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":1672000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q3_USD":21029000.0,"LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_0_Q3_USD":1398000.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"HeldToMaturitySecuritiesFairValue_0_Q3_USD":304494000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":28547.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_1_Q3_USD":-27624000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_3_Q3_USD":-45562000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0_Q3_USD":205722000.0,"HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_0_Q3_USD":21000.0,"SeveranceCosts1_3_Q3_USD":388000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":145000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":21761000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":82335000.0,"NonoperatingIncomeExpense_3_Q3_USD":23050000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":745000.0,"CommonStockSharesOutstanding_0_Q3_shares":41096319.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":-227000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":4595000.0,"PreferredStockSharesAuthorized_0_Q3_shares":10000000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":5374000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":447396000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3_Q3_USD":5.05,"PreferredStockValue_0_Q3_USD":null,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3_Q3_USD":10.13,"PaymentsToAcquireHeldToMaturitySecurities_3_Q3_USD":343320000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q3_pure":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_3_Q3_pure":0.0,"InvestmentIncomeInterest_1_Q3_USD":870000.0,"InvestmentIncomeInterest_3_Q3_USD":2406000.0,"IncreaseDecreaseInIncomeTaxesReceivable_3_Q3_USD":26555000.0,"IncomeTaxesReceivable_0_Q3_USD":27147000.0,"OperatingIncomeLoss_1_Q3_USD":-32240000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":2129000.0,"ProceedsFromConvertibleDebt_3_Q3_USD":3000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_3_Q3_shares":292991.0,"OperatingExpenses_3_Q3_USD":91405000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":-91461000.0,"PaymentsForTenantImprovements_3_Q3_USD":500000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-28822000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q3_shares":469472.0,"TaxesPayableCurrent_0_Q3_USD":451000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":4947106.0,"DisposalGroupIncludingDiscontinuedOperationAccountsPayable_0_Q3_USD":159000.0,"DeferredRentCreditNoncurrent_0_Q3_USD":1128000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":134000.0,"IncreaseDecreaseInIncomeTaxes_3_Q3_USD":451000.0,"StockholdersEquity_0_Q3_USD":415602000.0,"OtherLiabilitiesCurrent_0_Q3_USD":1011000.0,"ProfitLoss_3_Q3_USD":-41826000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_3_Q3_USD":6280000.0,"OperatingExpenses_1_Q3_USD":32240000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":13424000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":994000.0,"Ticker":"FMTX","CIK":"1538927","name":"FORMA THERAPEUTICS HOLDINGS, INC.","OfficialName":"Forma Therapeutics Holdings Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"416823275.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201112"}]